SCHEMBL11622018

SCHEMBL11622018

c1ccc(-c2n[nH]c3c2CCCC3)cc1

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.93
MAPK10 P53779 1/20 0.93
HTR7 P34969 7/20 0.70
MAPT P10636 2/20 0.65
HPGD P15428 2/20 0.65
GAA P10253 1/20 0.59
ALDH1A1 P00352 1/20 0.57
HTT P42858 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
USP7 Q93009 1/20 0.54
STAT3 P40763 2/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HTR1D P28221 3/20 0.49
HTR2A P28223 3/20 0.49
HTR2C P28335 3/20 0.49
HTR1E P28566 3/20 0.49
HTR2B P41595 3/20 0.49
HTR6 P50406 3/20 0.49
HTR1A P08908 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1513073 0.98 LMNA (0.90) LMNAMAPK10HTR7MAPTHPGD
SCHEMBL646266 0.96 LMNA (1.00) LMNAMAPK10HTR7MAPTHPGD
SCHEMBL4471607 0.82 MAPT (0.93) LMNAMAPK10HTR7MAPTHPGD
SCHEMBL20546703 0.82 HTR7 (1.00) LMNAMAPK10HTR7HTR1DHTR2A
SCHEMBL23722539 0.82 LMNA (0.64) LMNAMAPK10HTR7MAPTHPGD
SCHEMBL1250659 0.79 LMNA (0.60) LMNAMAPK10HTR7NPSR1
SCHEMBL2851304 0.77 HTR7 (0.79) LMNAMAPK10HTR7HTR1DHTR2A
SCHEMBL10818201 0.77 HTR7 (0.79) LMNAMAPK10HTR7HTR1DHTR2A
SCHEMBL10296211 0.76 MAPT (0.59) LMNAMAPK10HTR7MAPTHPGD
SCHEMBL12643304 0.76 LMNA (0.61) LMNAMAPK10HTR7MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238173-A1 MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 INHIBITORS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-08-05 US disclosed
EP-3802498-A1 MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 INHIBITORS Yeda Research and Development Co. Ltd (IL) 2021-04-14 EP disclosed
CN-112236414-A Mitogen-activated protein kinase 7 inhibitors 耶达研究及发展有限公司 2021-01-15 CN disclosed
US-4072498-A HERBICIDES THE UPJOHN COMPANY (US) 1978-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238173-A1 MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 INHIBITORS MAPK7, MAP2K7, MAP3K7 LMNA 2172/4885MAPK10 50/4885HTR7 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.